A longitudinal mirror-image assessment of morbidity in bipolar disorder

European Psychiatry

Volumn 40, Issue , 2017, Pages 55-59

  Martino, D J ^a,b   Samame C ^a,b   Marengo, E ^a   Igoa, A ^a   Scapola M ^a   Strejilevich, S A ^a,c  

^a FAVALORO UNIVERSITY   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c INSTITUTE OF COGNITIVE NEUROLOGY INECO   (Argentina)

Author keywords

Cycle length; Long term; Recurrences; Staging; Time spent ill

Indexed keywords

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL ASSESSMENT; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; SYMPTOMATOLOGY; COMORBIDITY; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; SEVERITY OF ILLNESS INDEX;

ADULT; BIPOLAR DISORDER; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX;

EID: 84995680626     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2016.06.010     Document Type: Article

References (40)

1. [1] Goodwin, F.K., Jamison, K.R., Manic-depressive illness: bipolar disorder and recurrent depression. 2nd ed., 2007, Oxford University Press, New York, 126–128 [Chapter 4].
2. [2] Berk, M., Hallam, K.T., McGorry, P.D., The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J Affect Disord 100 (2007), 279–281.
3. [3] Berk, M., Neuroprogression: pathways to progressive brain changes in bipolar disorder. Int J Neuropsychopharmacol 12 (2009), 441–445.
4. [4] Berk, M., Berk, L., Dodd, S., Cotton, S., Macneil, C., Daglas, R., et al. Stage managing bipolar disorder. Bipolar Disord 16:5 (2014), 471–477.
5. [5] Kapczinski, F., Dias, V.V., Kauer-Sant'Anna, M., Frey, B.N., Grassi-Oliveira, R., Colom, F., et al. Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother 9:7 (2009), 957–966.
6. [6] Post, R.M., Fleming, J., Kapczinski, F., Neurobiological correlates of illness progression in the recurrent affective disorders. J Psychiatric Res 46 (2012), 561–573.
7. [7] Barclay RM, translator; Robertson GM (Ed.). English translation of sections of Kraepelin's 1920 revision of the eighth edition of 1909, also revised in 1913, of Psychiatrie: Ein Kurzes Lehrbuch für Studirende und rtze Kraepelin, E., 1921. Manic-Depressive Insanity and Paranoia. E. and S. Livingstone, Edinburgh.
8. [8] Angst, J., Baastrup, P., Grof, P., Hippius, H., Poeldinger, W., Weis, P., Course of monopolar depression and bipolar psychoses. Psychiatr Neurol Neurochir 76 (1973), 489–500.
9. [9] Post, R.M., Leverich, G.S., Altshuler, L., Mikalauskas, K., Lithium-discontinuation-induced refractoriness: preliminary observations. Am J Psychiatry 149 (1992), 1727–1730.
10. [10] Zis, A.P., Grof, P., Webster, M.A., Goodwin, F.K., Cyclicity of affective disorders and its modifications by drugs: prediction of relapse in recurrent affective disorder. Psychopharmacol Bull 16 (1980), 47–49.
11. [11] Kessing, L.V., Andersen, P.K., Mortensen, P.B., Bolwig, T.G., Recurrence in affective disorder. I. Case register study. Br J Psychiatry 172 (1998), 23–28.
12. [12] Lundquist, G., Prognosis and course in manic-depressive psychoses: follow-up study of 319 first-admissions. Acta Psychiatr Neurol 20:Suppl. 35 (1945), 56–68.
13. [13] Bratfos, O., Haug, J.O., Course of manic-depressive psychosis. Follow-up investigation of 215 patients. Acta Psychiatr Scand 44 (1968), 89–112.
14. [14] Fukuda, K., Etoh, T., Iwadate, T., Atsushi, I., Course and prognosis of manic-depressive psychosis: quantitative analysis of episodes and intervals. Tohoku J Exp Med 139 (1993), 299–307.
15. [15] Winokur, G., Coryell, W., Akiskal, H.S., Endicott, J., Keller, M., Mueller, T., Manic-depressive (bipolar) disorder: course in light of a prospective ten-year follow-up of 131 patients. Acta Psychiatr Scand 89 (1994), 102–110.
16. [16] Martino, D.J., Marengo, E., Igoa, A., Scápola, M., Urtueta-Baamonde, M., Strejilevich, S.A., Accuracy of the number of previous episodes reported by patients with bipolar disorder. Compr Psychiatry 65 (2016), 122–127.
17. [17] Slater, E., Zur Periodik des manisch-depressiven Irreseins. Z Gesamte Neurolog Psychiatr 162 (1938), 794–801.
18. [18] Oepen, G., Baldessarini, R.J., Salvatore, P., Slater, E., On the periodicity of manic-depressive insanity, by Eliot Slater (1938): translated excerpts and commentary. J Affect Disord 78 (2004), 1–9.
19. [19] Kessing, L.V., Olsen, E.W., Andersen, P.K., Recurrence in affective disorder: analyses with frailty models. Am J Epidemiol 149:5 (1999), 404–411.
20. [20] Kessing, L.V., Hansen, M.G., Andersen, P.K., Angst, J., The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders – a life-long perspective. Acta Psychiatr Scand 109:5 (2004), 339–344.
21. [21] Kessing, L.V., Hansen, M.G., Andersen, P.K., Course of illness in depressive and bipolar disorders: naturalistic study, 1994–1999. Br J Psychiatry 185 (2004), 372–377.
22. [22] Turvey, C.L., Coryell, W.H., Solomon, D.A., Leon, A.C., Endicott, J., Keller, M.B., et al. Long-term prognosis of bipolar I disorder. Acta Psychiatr Scand 99 (1999), 110–119.
23. [23] Baldessarini, R.J., Salvatore, P., Khalsa, H.M., Imaz-Etxeberria, H., Gonzalez-Pinto, A., Tohen, M., Episode cycles with increasing recurrences in first-episode bipolar-I disorder patients. J Affect Disord 136 (2012), 149–154.
24. [24] First, M., Spitzer, R., Gibbon, M., Williams, J.B., Structured clinical interview for DSM-IV axis i disorders-clinical version (SCID-CV). 1996, American Psychiatry Press, Washington, DC.
25. [25] Peralta, V., Cuesta, M., Escala Clínica de Intensidad, Frecuencia y Duración del Tratamiento Psicofarmacológico (EscalaIFD). 2002, Virgen del Camino Hospital, Pamplona, Spain.
26. [26] Martino, D.J., Marengo, E., Igoa, A., Scápola, M., Ais, E., Perinot, L., et al. Neurocognitive and symptomatic predictors of functional outcome in bipolar disorder: a prospective 1-year follow-up study. J Affect Disord 116 (2009), 37–42.
27. [27] Strejilevich, S.A., Martino, D.J., Teitelbaum, J., Murru, A., Fassi, G., Marengo, E., et al. Mood instability and functional recovery in bipolar disorders. Acta Psychiatr Scand 128:3 (2013), 194–202.
28. [28] Kessing, L.V., Mortensen, P.B., Bolwig, T.G., Clinical definitions of sensitisation in affective disorder: a case register study of prevalence and prediction. J Affect Disord 47 (1998), 31–39.
29. [29] Burdick, K.E., Russo, M., Frangou, S., Mahon, K., Braga, R.J., Shanahan, M., et al. Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications. Psychol Med 44:14 (2014), 3083–3096.
30. [30] Martino, D.J., Strejilevich, S.A., Marengo, E., Ibañez, A., Scápola, M., Igoa, A., Toward the identification of neurocognitive subtypes in euthymic patients with bipolar disorder. J Affect Disord 167 (2014), 118–124.
31. [31] Strakowski, S.M., Keck, P.E. Jr., McElroy, S.L., West, S.A., Sax, K.W., Hawkins, J.M., et al. Twelve-month outcome after a first hospitalization for affective psychosis. Arch Gen Psychiatry 55:1 (1998), 49–55.
32. [32] Tohen, M., Waternaux, Ch.M., Tsuang, M.T., Outcome in mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 47 (1990), 1106–1111.
33. [33] Robinson, L., Ferrier, N., Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord 8 (2006), 103–116.
34. [34] Jaeger, J., Berns, S., Loftus, S., Gonzalez, C., Czobor, P., Neurocognitive test preformance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder. Bipolar Disord 9 (2007), 93–102.
35. [35] Reinares, M., Papachristou, E., Harvey, P., Mar Bonnín, C., Sánchez-Moreno, J., Torrent, C., et al. Yoward a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome. J Affect Disord 144:1–2 (2013), 65–71.
36. [36] Samamé, C., Martino, D.J., Strejilevich, S.A., Longitudinal course of cognitive deficits in bipolar disorder: a meta-analytic study. J Affect Disord 164 (2014), 130–138.
37. [37] Martino, D.J., Samamé, C., Marengo, E., Igoa, A., Strejilevich, S.A., A critical overview of the clinical evidence supporting the concept of neuroprogression in bipolar disorder. Psychiatry Res 235 (2016), 1–6.
38. [38] Judd, L.L., Akiskal, H.S., Schetler, P., Endicott, J., Maser, J.D., Solomon, D.A., et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 59 (2002), 530–537.
39. [39] Judd, L.L., Akiskal, H.S., Schetler, P., Coryell, W., Endicott, J., Maser, J.D., et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 60 (2003), 261–269.
40. [40] Cohen, P., Cohen, J., The clinician's illusion. Arch Gen Psychiatry 41:12 (1984), 1178–2118.